{"id":"https://openalex.org/W7169695409","doi":null,"title":"Impact of GLP-1 receptor agonists on renal function and weight loss in patients with chronic kidney disease and obesity: a systematic review and meta-analysis","display_name":"Impact of GLP-1 receptor agonists on renal function and weight loss in patients with chronic kidney disease and obesity: a systematic review and meta-analysis","alternate_titles":[],"publication_year":2026,"publication_date":"2026-03-20","ids":{"openalex":"https://openalex.org/W7169695409"},"language":"en","primary_location":{"id":"pmh:oai:amsdottorato.cib.unibo.it:12747","doi":null,"is_oa":false,"landing_page_url":"https://amsdottorato.unibo.it/id/eprint/12747/1/Hu_Lilio_tesi.pdf","pdf_url":"https://amsdottorato.unibo.it/id/eprint/12747/1/Hu_Lilio_tesi.pdf","source":{"id":"https://openalex.org/S4306400630","display_name":"AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I9360294","host_organization_name":"University of Bologna","host_organization_lineage":["https://openalex.org/I9360294"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Doctoral Thesis"},"parent_works":[],"lineage":["https://openalex.org/W7169695409"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5141129712","display_name":"Lilio <1993> Hu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Hu, Lilio <1993>","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5141129712"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.45559999346733093,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.45559999346733093,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.36469998955726624,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.13600000739097595,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9810000061988831},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9670000076293945},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.9990000128746033},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.9399999976158142},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.8579999804496765},{"id":"https://openalex.org/keywords/urinary-albumin-creatinine-ratio","display_name":"urinary albumin-creatinine ratio","score":0.8460000157356262},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate","display_name":"estimated glomerular filtration rate","score":0.9850000143051147},{"id":"https://openalex.org/keywords/acute-kidney-injury","display_name":"acute kidney injury","score":0.996999979019165}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9125000238418579},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.746999979019165},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.6581000089645386},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6431999802589417},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6068999767303467},{"id":"https://openalex.org/C2780586474","wikidata":"https://www.wikidata.org/wiki/Q332428","display_name":"Overweight","level":3,"score":0.6017000079154968},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5141000151634216},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.5001999735832214},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.46050000190734863},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4578999876976013},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4027999937534332},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.3921000063419342},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.3855000138282776},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3684999942779541},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.3449000120162964},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3294000029563904},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.32269999384880066},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.313400000333786},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.26899999380111694},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.26600000262260437}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:amsdottorato.cib.unibo.it:12747","doi":null,"is_oa":false,"landing_page_url":"https://amsdottorato.unibo.it/id/eprint/12747/1/Hu_Lilio_tesi.pdf","pdf_url":"https://amsdottorato.unibo.it/id/eprint/12747/1/Hu_Lilio_tesi.pdf","source":{"id":"https://openalex.org/S4306400630","display_name":"AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I9360294","host_organization_name":"University of Bologna","host_organization_lineage":["https://openalex.org/I9360294"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Doctoral Thesis"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402679370","https://openalex.org/W4415426068","https://openalex.org/W4404574654","https://openalex.org/W4380626384","https://openalex.org/W4403834863","https://openalex.org/W4406741409","https://openalex.org/W4415854994","https://openalex.org/W4403214672","https://openalex.org/W4414383412","https://openalex.org/W7161149629"],"abstract_inverted_index":{"Background:":[0],"Chronic":[1],"kidney":[2,201,286],"disease":[3],"(CKD)":[4],"and":[5,28,44,54,63,70,86,119,151,177,183,205,230,238,267],"obesity":[6,85],"are":[7,278],"major":[8],"public":[9],"health":[10],"concerns":[11],"with":[12,68,75,81,87,102,226,236,265],"significant":[13,141,194,227,243],"socioeconomic":[14],"implications.":[15],"While":[16],"Glucagon-like":[17],"peptide-1":[18],"receptor":[19,250],"agonists":[20,99,150,223,251],"(GLP-1)":[21],"can":[22],"be":[23],"effective":[24],"for":[25,175],"glycaemic":[26],"control":[27,138,152],"weight":[29,64,228],"loss,":[30],"their":[31,282],"impact":[32,53],"on":[33,60,247,275],"renal":[34,61,260,276],"outcomes":[35,179,277],"remains":[36],"unclear.":[37],"Objectives:":[38],"To":[39],"perform":[40],"a":[41,76],"systematic":[42],"review":[43],"meta-analysis":[45],"of":[46,58,78,199,232,259],"randomized":[47],"clinical":[48],"trials":[49],"to":[50,111,128,137,161,170,216,255,280],"evaluate":[51],"the":[52,55,197,257],"safety":[56],"profile":[57],"GLP-1":[59,98,149,204,222,249],"function":[62],"loss":[65,229],"in":[66,143,188,196,234,263,284],"patients":[67,80,235,264],"CKD":[69,237,266],"obesity.":[71,241,270],"Results:":[72],"Six":[73],"RCTs,":[74],"total":[77],"8.111":[79],"CKD,":[82],"overweight":[83,239,268],"or":[84,88,240,269],"without":[89],"diabetes":[90],"were":[91,100,224],"included.":[92],"At":[93],"26":[94],"weeks,":[95],"treatment":[96,189],"wih":[97],"associated":[101,225],"decreased":[103],"UACR":[104,176,233],"(MD":[105,121,154],"=":[106,114,117,122,131,134,155,164,167,181,211,219],"\u221224.01%;":[107],"95%":[108,125,158,213],"CI:":[109,126,159],"\u221236.11":[110],"\u221211.91,":[112],"p":[113,130,163,218],"0.0001;":[115],"I\u00b2":[116,133,166],"74.3%)":[118],"bodyweight":[120],"\u22123.23":[123],"kg;":[124],"\u22125.22":[127],"\u22121.25,":[129],"0.0014;":[132],"0%)":[135],"compared":[136],"groups.":[139],"No":[140,193,242],"difference":[142,195],"eGFR":[144,178],"change":[145],"was":[146,173,208,245],"observed":[147,174,209,246],"between":[148,203],"groups":[153,207],"0.62":[156],"mL/min/1.73m2;":[157],"\u20131.66":[160],"2.89,":[162],"0.35;":[165],"94%).":[168],"Moderate":[169],"substantial":[171],"heterogeneity":[172],"(I\u00b2":[180],"74.3%":[182],"94%,":[184],"respectively),":[185],"suggesting":[186],"variability":[187],"effects":[190],"across":[191],"studies.":[192],"risk":[198,258],"acute":[200],"injury":[202],"placebo":[206],"(OR":[210],"0.94;":[212],"CI,":[214],"0.78":[215],"1.13;":[217],"0.4268).":[220],"Conclusions:":[221],"reduction":[231],"effect":[244],"eGFR.":[248],"do":[252],"not":[253],"appear":[254],"increase":[256],"adverse":[261],"events":[262],"Further":[271],"long-term":[272],"studies":[273],"focusing":[274],"needed":[279],"clarify":[281],"role":[283],"preserving":[285],"function.":[287]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7169695409","counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2026-07-19T00:00:00"}
